Analysts Issue Forecasts for Cross Country Healthcare, Inc.’s FY2025 Earnings (NASDAQ:CCRN)

Cross Country Healthcare, Inc. (NASDAQ:CCRNFree Report) – Equities research analysts at William Blair dropped their FY2025 earnings per share (EPS) estimates for shares of Cross Country Healthcare in a research report issued on Thursday, August 1st. William Blair analyst T. Romeo now expects that the business services provider will earn $0.72 per share for the year, down from their prior estimate of $0.98. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $0.68 per share. William Blair also issued estimates for Cross Country Healthcare’s FY2026 earnings at $0.97 EPS.

A number of other analysts have also weighed in on CCRN. Truist Financial upped their target price on Cross Country Healthcare from $16.00 to $17.00 and gave the stock a “hold” rating in a report on Thursday, August 1st. Barrington Research cut their target price on Cross Country Healthcare from $24.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday, May 6th. Finally, Benchmark lowered their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.00.

Get Our Latest Stock Analysis on Cross Country Healthcare

Cross Country Healthcare Stock Performance

NASDAQ CCRN opened at $16.62 on Monday. The company has a market cap of $577.94 million, a PE ratio of 12.78, a P/E/G ratio of 2.57 and a beta of 0.63. The firm’s 50 day moving average price is $14.83 and its 200-day moving average price is $16.90. Cross Country Healthcare has a 52-week low of $12.87 and a 52-week high of $26.17.

Cross Country Healthcare (NASDAQ:CCRNGet Free Report) last released its quarterly earnings data on Wednesday, July 31st. The business services provider reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.04). The business had revenue of $339.77 million during the quarter, compared to analysts’ expectations of $334.75 million. Cross Country Healthcare had a return on equity of 7.29% and a net margin of 0.54%. The firm’s revenue was down 37.2% compared to the same quarter last year. During the same period last year, the company earned $0.69 earnings per share.

Insiders Place Their Bets

In other news, VP Cynthia Ann Grieco sold 1,945 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $17.21, for a total transaction of $33,473.45. Following the sale, the vice president now directly owns 7,605 shares of the company’s stock, valued at $130,882.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, VP Cynthia Ann Grieco sold 1,945 shares of Cross Country Healthcare stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $17.21, for a total transaction of $33,473.45. Following the completion of the sale, the vice president now owns 7,605 shares of the company’s stock, valued at $130,882.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Phillip Lyn Noe sold 9,646 shares of the company’s stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $14.19, for a total value of $136,876.74. Following the completion of the sale, the insider now owns 10,162 shares in the company, valued at approximately $144,198.78. The disclosure for this sale can be found here. Over the last quarter, insiders sold 39,077 shares of company stock valued at $608,946. Insiders own 4.90% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in CCRN. GAMMA Investing LLC acquired a new stake in Cross Country Healthcare during the 4th quarter worth about $28,000. Gladius Capital Management LP grew its holdings in Cross Country Healthcare by 37.1% during the fourth quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider’s stock worth $43,000 after acquiring an additional 515 shares during the period. nVerses Capital LLC purchased a new position in Cross Country Healthcare during the second quarter valued at approximately $50,000. Denali Advisors LLC lifted its holdings in Cross Country Healthcare by 3,885.5% in the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock valued at $103,000 after acquiring an additional 5,362 shares during the period. Finally, EMC Capital Management purchased a new stake in Cross Country Healthcare in the 1st quarter worth approximately $155,000. Hedge funds and other institutional investors own 96.03% of the company’s stock.

About Cross Country Healthcare

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.